Skip to NavigationSkip to content

Former Celgene CEO Bob Hugin loses in US midterm elections

Published on 07/11/18 at 12:06pm

Former Celgene CEO Bob Hugin has failed in his bid to win over the people of New Jersey, after voters last night elected Democratic candidate Bob Menendez in the US midterm elections.

Despite receiving nearly three times as much in campaign finance, it was announced that the republican candidate lost the New Jersey Senate election, gaining 43.8% of the vote in comparison to his opponent Menendez’s 53.1% share.

While Hugin was the recipient of a total $30,289,561, Menendez received $11,631,183 in comparison. Hugin was reported by the Associated Press to have loaned his campaign $36 million.

Nevertheless, despite an onslaught of attack ads, Menendez won out. However Hugin did win with a significant majority in the Republican primaries beating fellow republican Brian Goldberg with 75.1% of the vote. The enthusiasm did not however translate to the final result.

Having begun his career at J.P Morgan the Union City, New Jersey native and Princeton alumnus went on to transform New Jersey-based Celgene increasing the company’s headcount from 200 to 6000 over his nearly two decade career.

In his race to senate the business guru was also the recipient of an endorsement from President Donald Trump who tweeted: “Bob Hugin, successful all of his life, would be a Great Senator from New Jersey. He has my complete and total Endorsement! Get out and Vote for Bob.”

Louis Goss

Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches